How do different countries promote ethical and efficient organ transplantation? This blog series will explore the policy behind the decisions. This is Part 2 of the series.
How do different countries promote ethical and efficient organ transplantation? This blog series will explore the policy behind the decisions. This is Part 1 of the series.
In this blog, Sasha Lawson-Frost explores what moral values underpin or justify the practice of Evidence-Based Medicine, specifically in response to a recent article which stated “the policy side of evidence-based medicine is basically a form of rule utilitarianism”.
This blog discusses fundamental issues affecting healthcare research, which could undermine the field and mean that most medical research may be wrong. Issues discussed include: 1) contradictory findings 2) the illusion of high impact factor journals 3) the reproducibility crisis 4) a lack of translation of research findings from bench to bedside 5) medical reversal 6) bias 7) statistical issues and 8) conflicts of interest and unethical practice. The author then explores possible solutions to these.
Do placebos really promote physiological change or is it just the patient’s perspective? How are placebos used in practice? And how ethical is it to use placebos in clinical trials?
Ashline takes a look at ethical assessments and considerations in randomised controlled trials and cluster randomised controlled trials.
Conducting trials where the trialled therapeutic must be commenced urgently raises specific practical and ethical problems. Here I discuss a recent New England Journal of Medicine paper looking at the use of intracranial pressure monitoring for severe traumatic brain injury as an example of how these issues may affect a trial’s utility and how this can be managed.
PharmAware is a network of students committed to the use of the best evidence in healthcare.
Register to become an S4BE Contributor